GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:200123314 | Breast | IDC | regulation of apoptotic signaling pathway | 82/1434 | 356/18723 | 6.27e-20 | 5.93e-17 | 82 |
GO:200123414 | Breast | IDC | negative regulation of apoptotic signaling pathway | 49/1434 | 224/18723 | 1.45e-11 | 2.58e-09 | 49 |
GO:009719114 | Breast | IDC | extrinsic apoptotic signaling pathway | 42/1434 | 219/18723 | 2.56e-08 | 1.73e-06 | 42 |
GO:200123614 | Breast | IDC | regulation of extrinsic apoptotic signaling pathway | 32/1434 | 151/18723 | 1.07e-07 | 6.26e-06 | 32 |
GO:200123714 | Breast | IDC | negative regulation of extrinsic apoptotic signaling pathway | 19/1434 | 97/18723 | 1.22e-04 | 2.25e-03 | 19 |
GO:000150311 | Breast | IDC | ossification | 50/1434 | 408/18723 | 6.51e-04 | 8.04e-03 | 50 |
GO:000189413 | Breast | IDC | tissue homeostasis | 34/1434 | 268/18723 | 2.54e-03 | 2.28e-02 | 34 |
GO:200123324 | Breast | DCIS | regulation of apoptotic signaling pathway | 81/1390 | 356/18723 | 3.51e-20 | 3.31e-17 | 81 |
GO:200123424 | Breast | DCIS | negative regulation of apoptotic signaling pathway | 48/1390 | 224/18723 | 1.70e-11 | 3.22e-09 | 48 |
GO:009719123 | Breast | DCIS | extrinsic apoptotic signaling pathway | 40/1390 | 219/18723 | 9.43e-08 | 5.28e-06 | 40 |
GO:200123623 | Breast | DCIS | regulation of extrinsic apoptotic signaling pathway | 31/1390 | 151/18723 | 1.79e-07 | 9.04e-06 | 31 |
GO:200123723 | Breast | DCIS | negative regulation of extrinsic apoptotic signaling pathway | 18/1390 | 97/18723 | 2.52e-04 | 3.89e-03 | 18 |
GO:000189423 | Breast | DCIS | tissue homeostasis | 33/1390 | 268/18723 | 2.88e-03 | 2.48e-02 | 33 |
GO:000150321 | Breast | DCIS | ossification | 45/1390 | 408/18723 | 4.98e-03 | 3.72e-02 | 45 |
GO:2001233111 | Esophagus | ESCC | regulation of apoptotic signaling pathway | 256/8552 | 356/18723 | 4.11e-24 | 1.04e-21 | 256 |
GO:0097191111 | Esophagus | ESCC | extrinsic apoptotic signaling pathway | 159/8552 | 219/18723 | 4.12e-16 | 2.94e-14 | 159 |
GO:2001234111 | Esophagus | ESCC | negative regulation of apoptotic signaling pathway | 161/8552 | 224/18723 | 1.24e-15 | 8.09e-14 | 161 |
GO:2001236111 | Esophagus | ESCC | regulation of extrinsic apoptotic signaling pathway | 111/8552 | 151/18723 | 2.97e-12 | 1.18e-10 | 111 |
GO:00091002 | Esophagus | ESCC | glycoprotein metabolic process | 226/8552 | 387/18723 | 2.64e-07 | 3.94e-06 | 226 |
GO:2001237111 | Esophagus | ESCC | negative regulation of extrinsic apoptotic signaling pathway | 69/8552 | 97/18723 | 3.23e-07 | 4.55e-06 | 69 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
COL2A1 | SNV | Missense_Mutation | | c.1040N>C | p.Asp347Ala | p.D347A | P02458 | protein_coding | tolerated(0.08) | probably_damaging(0.968) | TCGA-66-2793-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
COL2A1 | SNV | Missense_Mutation | | c.242C>G | p.Pro81Arg | p.P81R | P02458 | protein_coding | deleterious(0.02) | benign(0.354) | TCGA-68-8250-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
COL2A1 | SNV | Missense_Mutation | | c.724C>A | p.Arg242Ser | p.R242S | P02458 | protein_coding | deleterious(0.04) | benign(0.369) | TCGA-85-8584-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
COL2A1 | SNV | Missense_Mutation | novel | c.2213G>T | p.Gly738Val | p.G738V | P02458 | protein_coding | deleterious(0) | probably_damaging(0.935) | TCGA-85-A4JC-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | unknown | PD |
COL2A1 | SNV | Missense_Mutation | novel | c.769N>T | p.Ala257Ser | p.A257S | P02458 | protein_coding | tolerated(0.63) | benign(0.022) | TCGA-NC-A5HQ-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Chemotherapy | carboplatin | CR |
COL2A1 | SNV | Missense_Mutation | novel | c.2354G>T | p.Arg785Leu | p.R785L | P02458 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-CN-6010-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
COL2A1 | SNV | Missense_Mutation | novel | c.3956N>G | p.Thr1319Ser | p.T1319S | P02458 | protein_coding | tolerated(0.09) | benign(0.017) | TCGA-CR-7364-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
COL2A1 | SNV | Missense_Mutation | | c.739N>G | p.Pro247Ala | p.P247A | P02458 | protein_coding | tolerated(0.11) | benign(0.093) | TCGA-CR-7364-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
COL2A1 | SNV | Missense_Mutation | rs777416478 | c.4376N>A | p.Arg1459His | p.R1459H | P02458 | protein_coding | deleterious(0.02) | probably_damaging(0.995) | TCGA-CR-7389-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | paclitaxel | CR |
COL2A1 | SNV | Missense_Mutation | rs121912886 | c.4316C>T | p.Thr1439Met | p.T1439M | P02458 | protein_coding | deleterious(0.01) | possibly_damaging(0.664) | TCGA-CV-5970-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |